NCT04907292 is a clinical trial of Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool in Quality of Recovery, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital.

Who is sponsoring NCT04907292?

NCT04907292 is sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital.

What drugs are being tested in NCT04907292?

Interventions in NCT04907292: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool.

What condition does NCT04907292 study?

NCT04907292 studies Quality of Recovery.

Is NCT04907292 still recruiting?

NCT04907292 is currently completed. Last updated 31 January 2022.

Last reviewed 2022-01-31 · How we verify

NCT04907292

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Recovery After Unplanned and Planned Cesarean Deliveries - an Application of ObsQoR-10

Completed Last updated 31 January 2022

What this trial tests

trial testing Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool in Quality of Recovery in 112 participants. Completed in 9 November 2021.

Timeline

16 August 2021

Primary endpoint
2 November 2021

9 November 2021

Quick facts

Lead sponsor	Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	112
Start date	16 August 2021
Primary completion	2 November 2021
Estimated completion	9 November 2021
Sites	1 location across Canada

Drugs / interventions tested

Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

Conditions studied

Quality of Recovery — all drugs for Quality of Recovery →

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Who can join

Adults 18 to 55, female only, with Quality of Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Canada, 29.1% of annual births are via cesarean deliveries (CD). The literature shows that almost 24% of CDs are unplanned. Existing evidence suggests that unplanned cesarean delivery, compared to elective cesarean, may be associated with poor maternal recovery, longer postpartum hospital stays and more opioid requirements after surgery. Since the establishment of the Enhanced Recovery After Cesarean protocols, specific care pathways have been implemented with the aim of optimizing recovery after CD and to reduce the costs to the health care system. However, the majority of unplanned cesarean receive the same postoperative anesthetic, obstetric and nursing care as the elective CDs. Looking at the actual information about maternal recovery after unplanned CD, the investigators found that there is a paucity of literature examining this topic utilizing validated, patient-oriented quality of recovery tools. Recently, Obstetric Quality of Recovery-10 scoring tool (ObsQoR-10), a new patient-focused outcome instrument for postpartum recovery, it has been validated for all types of deliveries, in the inpatient setting. ObsQoR-10 tool aims to measure quantitatively functional recovery at 24 hours postpartum. It includes 10 questions on a 0 to 10 scale, aimed at pain management, the adverse effects of narcotics and the perception of recovery by the patient. The aim of this study is to determine the quality of recovery from unplanned cesarean deliveries compared to planned ones using a validated tool for recovery after cesarean delivery (ObsQoR-10 tool). The investigators hypothesize that quality of recovery as measured by the Obs-QoR10 for unplanned cesarean deliveries will be lower than the planned CDs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Quality of Recovery

Currently open trials in the same condition.

NCT06584825 — Enhanced Vitals Monitoring After Major Surgery Trial · NA · recruiting
NCT06948383 — SPSIPB vs. SAPB in Breast Surgery · NA · active not recruiting

Other Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

Trials by the same sponsor.

NCT06589687 — The Patient AS EDUcator in Anesthesia: Exploring the Patients' Experience During and After Unexpected Cesarean Delivery · completed
NCT06589661 — The Patient AS EDUcator in Anesthesia: Exploring the Patients' Experience During and After Unexpected Cesarean Delivery · completed
NCT06368583 — The Patient AS EDUcator in Anesthesia: Exploring the Patients' and Providers' Experience During Neuraxial Labour Analges · completed
NCT06368570 — The Patient AS EDUcator in Anesthesia: Exploring the Patients' Experience During Routine Cesarean Delivery · completed
NCT06318715 — Modified Deep Extubation vs. Standard Awake Extubation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04907292 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Last refreshed: 31 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04907292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing